Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Moussa B. H. Youdim And Notquantitative real‐time PCR

List of bibliographic references

Number of relevant bibliographic references: 9.
Ident.Authors (with country if any)Title
001036 Orly Weinreb [Israël] ; Tamar Amit [Israël] ; Orit Bar-Am [Israël] ; Moussa B. H. Youdim [Israël]Induction of Neurotrophic Factors GDNF and BDNF Associated with the Mechanism of Neurorescue Action of Rasagiline and Ladostigil
001178 Moussa B. H. Youdim [Israël] ; Dale Edmondson [États-Unis] ; Keith F. Tipton [Irlande (pays)]The therapeutic potential of monoamine oxidase inhibitors
001197 Anna L. Bartels [Pays-Bas] ; Bauke M. De Jong [Pays-Bas] ; Nir Giladi [Israël] ; Joanna D. Schaafsma [Pays-Bas] ; R. Paul Maguire [Pays-Bas] ; Lammy Veenma [Pays-Bas] ; Jan Pruim [Pays-Bas] ; Yacov Balash [Israël] ; Moussa B. H. Youdim [Israël] ; Klaus L. Leenders [Pays-Bas]Striatal dopa and glucose metabolism in PD patients with freezing of gait
001436 Moussa B. H. Youdim [Israël] ; Orit Bar Am [Israël] ; Merav Yogev-Falach [Israël] ; Orly Weinreb [Israël] ; Wakako Maruyama [Japon] ; Makato Naoi [Japon] ; Tamar Amit [Israël]Rasagiline: Neurodegeneration, neuroprotection, and mitochondrial permeability transition
001453 Orly Weinreb [Israël] ; Tamar Amit [Israël] ; Orit Bar-Am [Israël] ; Orly Chillag-Talmor [Israël] ; Moussa B. H. Youdim [Israël]Novel Neuroprotective Mechanism of Action of Rasagiline Is Associated with Its Propargyl Moiety: Interaction of Bcl‐2 Family Members with PKC Pathway
001616 Moussa B. H. Youdim [Israël] ; Galia Stephenson [Israël] ; Dorit Ben Shachar [Israël]Ironing Iron Out in Parkinson's Disease and Other Neurodegenerative Diseases with Iron Chelators: A Lesson from 6‐Hydroxydopamine and Iron Chelators, Desferal and VK‐28
001617 Luigi Zecca [Italie] ; Moussa B. H. Youdim [Israël] ; Peter Riederer [Allemagne] ; James R. Connor [États-Unis] ; Robert R. Crichton [Belgique]Iron, brain ageing and neurodegenerative disorders
001A10 Moussa B. H. Youdim [Israël] ; A. Wadia [États-Unis] ; W. Tatton [États-Unis] ; Marta Weinstock [Israël]The Anti‐Parkinson Drug Rasagiline and Its Cholinesterase Inhibitor Derivatives Exert Neuroprotection Unrelated to MAO Inhibition in Cell Culture and in Vivo
002665 Manfred Gerlach [Allemagne] ; Peter Riederer [Allemagne] ; Horst Przuntek [Allemagne] ; Moussa B. H. Youdim [Israël]MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024